Jim Simons acquired 4.7k Spruce Biosciences shares worth $219k. That's 0.00% of their equity portfolio (2642nd largest holding). The first Spruce Biosciences trade was made in Q3 2021. Since then Jim Simons bought shares nine more times and sold shares on seven occasions. The investor's estimated purchase price is $264k, resulting in a loss of 17%.